Transcription of Assessment report - Europa
{{id}} {{{paragraph}}}
30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged. 21 May 2015 EMA/444458/2015 Rev 1 Committee for Medicinal Products for Human Use (CHMP) Assessment report Keytruda International non- proprietary name: pembrolizumab Procedure No. EMEA/H/C/003820/0000 Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. Page 2/160 Table of contents 1. Background information on the procedure .. 7 Submission of the dossier.
Telephone +44 (0)20 +44 (0)20 3660 6000 Facsimile 3660 5555 ... Assessment report . Keytruda . International non-proprietary name: pembrolizumab . Procedure No. EMEA/H/C/003820/0000 Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature ... the P IP P/0059/2014 was not yet completed a s some
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}